Abstract
Postmastectomy radiation therapy (PMRT) in high-risk breast cancer patients reduces the risk of locoregional recurrence and improves disease-free and overall survival. This has been established in randomized trials where patients were also treated with systemic therapy indicating that in radically operated breast cancer patients, both optimal systemic and optimal locoregional therapies are important and contribute to improved prognosis of the patient.
The target of PMRT is the chest wall, and depending on tumour risk parameters, all or part of the lymph node areas draining the glandular breast tissue are included in the irradiated volume. Data pointing to the effect of including the internal mammary lymph nodes are highlighted. The ESTRO consensus for target delineation is presented, and technical issues like dose, fractionation, field arrangements, breathing-adapted respiratory techniques and use of bolus are discussed.
Balancing the gain and risk from PMRT in the individual patient is very important, and future directions in providing more individualized therapy are mentioned.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Halsted WS (1895) The results of operations for cure of cancer of the breast performed at Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Bull 4:297–319
Halsted WS (1907) The results of radical operations for the cure of carcinoma of the breast. Ann Surg 46:1–6
Fisher B (1980) Laboratory and clinical research in breast cancer—The David A. Karnofsky memorial lecture. Cancer Res 40:3863–3874
Koscielny S, Tubiana M, Le MG (1984) Breast cancer: relationship between the size of the primary tumour and the probability of metastatic dissemination. Br J Cancer 49(6):709–715
Hellman S (1994) Karnofsky memorial lecture: natural history of breast cancers. J Clin Oncol 12:2229–2234
Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, Nomura Y, Sakai K, Sugimachi K, Tominaga T, Uchino J, Yoshida M, Haybittle JL, Davies C, Harvey VJ, Holdaway TM, Kay RG, Mason BH, Forbes JF, Wilcken N, Gnant M, Jakesz R, Ploner M, Yosef HMA, Focan C et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106
Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337(14):949–955
Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, Kamby C, Kjaer M, Gadeberg CC, Rasmussen BB, Blichert-Toft M, Mouridsen HT (1999) Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353(9165):1641–1648
Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337(14):956–962
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J (2006) Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol 24(15):2268–2275
Muss HB, Cooper MR, Brockschmidt JK, Ferree C, Richards F, White DR, Jackson DV, Spurr CL (1991) A randomized trial of chemotherapy (L-PAM vs CMF) and irradiation for node positive breast cancer. Eleven year follow-up of a Piedmont Oncology Association trial. Breast Cancer Res Treat 19(2):77–84
Blomqvist C, Tiusanen K, Elomaa I, Rissanen P, Hietanen T, Heinonen E, Grohn P (1992) The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial. Br J Cancer 66(6):1171–1176
Griem KL, Henderson IC, Gelman R, Ascoli D, Silver B, Recht A, Goodman RL, Hellman S, Harris JR (1987) The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol 5(10):1546–1555
Velez-Garcia E, Carpenter JT Jr, Moore M, Vogel CL, Marcial V, Ketcham A, Singh KP, Bass D, Bartolucci AA, Smalley R (1992) Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer 28A(11):1833–1837
McArdle CS, Crawford D, Dykes EH, Calman KC, Hole D, Russell AR, Smith DC (1986) Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg 73(4):264–266
Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW, Tormey DC, Veeder M, Falkson G (1997) The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group. Cancer 79(6):1138–1149
Tennvall-Nittby L, Tengrup I, Landberg T (1993) The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol 32(6):641–646
Ryden S, Ferno M, Moller T, Aspegren K, Bergljung L, Killander D, Landberg T (1992) Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial. Acta Oncol 31(2):271–274
Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12(3):447–453
Hojris I, Overgaard M, Christensen JJ, Overgaard J (1999) Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354(9188):1425–1430
McGale P, Darby SC, Hall P, Adolfsson J, Bengtsson NO, Bennet AM, Fornander T, Gigante B, Jensen MB, Peto R, Rahimi K, Taylor CW, Ewertz M (2011) Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 100(2):167–175
Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol 24(9):2206–2223
Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(5):1539–1569
Taylor ME, Haffty BG, Rabinovitch R, Arthur DW, Halberg FE, Strom EA, White JR, Cobleigh MA, Edge SB (2009) ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. Int J Radiat Oncol Biol Phys 73(4):997–1002
Truong PT, Olivotto IA, Whelan TJ, Levine M (2004) Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 170(8):1263–1273
McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127–2135
Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, Zackrisson S, Cardoso F (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8–30
Wenz F, Sperk E, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Piroth MD, Sautter-Bihl ML, Sedlmayer F, Souchon R, Fussl C, Sauer R (2014) DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol 190(8):705–714
Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete SA, Kirova YM, Pignol JP, Remouchamps V, Verhoeven K, Weltens C, Arenas M, Gabrys D, Kopek N, Krause M, Lundstedt D, Marinko T, Montero A, Yarnold J, Poortmans P (2015) ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol 114(1):3–10
Poortmans PM, Collette S, Kirkove C, Van LE, Budach V, Struikmans H, Collette L, Fourquet A, Maingon P, Valli M, De WK, Marnitz S, Barillot I, Scandolaro L, Vonk E, Rodenhuis C, Marsiglia H, Weidner N, Van TG, Glanzmann C, Kuten A, Arriagada R, Bartelink H, Van Den BW (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327
Whelan TJ, Olivotto IA, Parulekar WR, Ackerman I, Chua BH, Nabid A, Vallis KA, White JR, Rousseau P, Fortin A, Pierce LJ, Manchul L, Chafe S, Nolan MC, Craighead P, Bowen J, McCready DR, Pritchard KI, Gelmon K, Murray Y, Chapman JA, Chen BE, Levine MN (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316
Thorsen LB, Offersen BV, Dano H, Berg M, Jensen I, Pedersen AN, Zimmermann SJ, Brodersen HJ, Overgaard M, Overgaard J (2016) DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer. J Clin Oncol 34:314–320
Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362(6):513–520
Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR (2013) The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol 14(11):1086–1094
Feigenberg SJ, Price MN, Benda RK, Morris CG (2003) Postmastectomy radiotherapy: patterns of recurrence and long-term disease control using electrons. Int J Radiat Oncol Biol Phys 56(3):716–725
Overgaard M, Christensen JJ (2008) Postoperative radiotherapy in DBCG during 30 years. Techniques, indications and clinical radiobiological experience. Acta Oncol 47(4):639–653
Kirova YM, Campana F, Fournier-Bidoz N, Stilhart A, Dendale R, Bollet MA, Fourquet A (2007) Postmastectomy electron beam chest wall irradiation in women with breast cancer: a clinical step toward conformal electron therapy. Int J Radiat Oncol Biol Phys 69(4):1139–1144
Spierer MM, Hong LX, Wagman RT, Katz MS, Spierer RL, McCormick B (2004) Postmastectomy CT-based electron beam radiotherapy: dosimetry, efficacy, and toxicity in 118 patients. Int J Radiat Oncol Biol Phys 60(4):1182–1189
Gaffney DK, Leavitt DD, Tsodikov A, Smith L, Watson G, Patton G, Gibbs FA, Stewart JR (2001) Electron arc irradiation of the postmastectomy chest wall with CT treatment planning: 20-year experience. Int J Radiat Oncol Biol Phys 51(4):994–1001
Pierce LJ, Butler JB, Martel MK, Normolle DP, Koelling T, Marsh RB, Lichter AS, Fraass BA (2002) Postmastectomy radiotherapy of the chest wall: dosimetric comparison of common techniques. Int J Radiat Oncol Biol Phys 52(5):1220–1230
Thomsen MS, Berg M, Nielsen HM, Pedersen AN, Overgaard M, Ewertz M, Block T, Brodersen HJ, Caldera C, Jakobsen E, Kamby C, Kjaer-Kristoffersen F, Klitgaard D, Nielsen MM, Stenbygaard L, Zimmermann SJ, Grau C (2008) Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncol 47(4):654–661
Korreman SS, Pedersen AN, Aarup LR, Nottrup TJ, Specht L, Nystrom H (2006) Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys 65(5):1375–1380
Nissen HD, Appelt AL (2013) Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 106(1):28–32
Hjelstuen MH, Mjaaland I, Vikstrom J, Dybvik KI (2012) Radiation during deep inspiration allows loco-regional treatment of left breast and axillary-, supraclavicular- and internal mammary lymph nodes without compromising target coverage or dose restrictions to organs at risk. Acta Oncol 51(3):333–344
Lutz CM, Poulsen PR, Fledelius W, Offersen BV, Thomsen MS (2015) Setup error and motion during deep inspiration breath-hold breast radiotherapy measured with continuous portal imaging. Acta Oncol 18:1–8
Jagsi R, Moran J, Marsh R, Masi K, Griffith KA, Pierce LJ (2010) Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys 78(5):1594–1603
Nichols GP, Fontenot JD, Gibbons JP, Sanders ME (2014) Evaluation of volumetric modulated arc therapy for postmastectomy treatment. Radiat Oncol 9:66
Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, Wai ES, Otto K (2010) Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 76(1):287–295
Stovall M, Smith SA, Langholz BM, Boice JD Jr, Shore RE, Andersson M, Buchholz TA, Capanu M, Bernstein L, Lynch CF, Malone KE, Anton-Culver H, Haile RW, Rosenstein BS, Reiner AS, Thomas DC, Bernstein JL (2008) Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys 72(4):1021–1030
bo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, Giordano FA, Herskind C, Steil V, Wenz F, Glatting G (2014) Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiother Oncol 110(3):471–476
Grantzau T, Thomsen MS, Vaeth M, Overgaard J (2014) Risk of second primary lung cancer in women after radiotherapy for breast cancer. Radiother Oncol 111(3):366–373
Depauw N, Batin E, Daartz J, Rosenfeld A, Adams J, Kooy H, Macdonald S, Lu HM (2015) A novel approach to postmastectomy radiation therapy using scanned proton beams. Int J Radiat Oncol Biol Phys 91(2):427–434
Shiau AC, Chiu MC, Chen TH, Chiou JF, Shueng PW, Chen SW, Chen WL, Kuan WP (2012) Surface and superficial dose dosimetric verification for postmastectomy radiotherapy. Med Dosim 37(4):417–424
Vu TT, Pignol JP, Rakovitch E, Spayne J, Paszat L (2007) Variability in radiation oncologists' opinion on the indication of a bolus in post-mastectomy radiotherapy: an international survey. Clin Oncol (R Coll Radiol) 19(2):115–119
Tieu MT, Graham P, Browne L, Chin YS (2011) The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence. Int J Radiat Oncol Biol Phys 81(3):e165–e171
Kronowitz SJ (2012) Current status of implant-based breast reconstruction in patients receiving postmastectomy radiation therapy. Plast Reconstr Surg 130(4):513e–523e
Ribuffo D, Lo TF, Giannitelli SM, Urbini M, Tortora L, Mozetic P, Trombetta M, Basoli F, Licoccia S, Tombolini V, Cassese R, Scuderi N, Rainer A (2015) The effect of post-mastectomy radiation therapy on breast implants: unveiling biomaterial alterations with potential implications on capsular contracture. Mater Sci Eng C Mater Biol Appl 57:338–343
Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26(9):1419–1426
Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Borresen-Dale AL, Sorlie T, Frigessi A, Overgaard J (2014) Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Clin Cancer Res 20(20):5272–5280
Tramm T, Kyndi M, Myhre S, Nord S, Alsner J, Sorensen FB, Sorlie T, Overgaard J (2014) Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer. Acta Oncol 53(10):1337–1346
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Offersen, B.V., Thomsen, M.S. (2017). Postmastectomy Radiation Therapy of Early Breast Cancer. In: Veronesi, U., Goldhirsch, A., Veronesi, P., Gentilini, O., Leonardi, M. (eds) Breast Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48848-6_53
Download citation
DOI: https://doi.org/10.1007/978-3-319-48848-6_53
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48846-2
Online ISBN: 978-3-319-48848-6
eBook Packages: MedicineMedicine (R0)